Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BHF
BHF logo

BHF Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Brighthouse Financial Inc (BHF) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
65.270
1 Day change
0.60%
52 Week Range
66.330
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

BHF is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The chart is constructive, but the setup is not compelling enough to call an immediate buy: there is no strong proprietary buy signal, no recent news catalyst, no analyst upgrade momentum, and no clear financial update to confirm accelerating fundamentals. For an impatient investor who does not want to wait for an optimal entry, I would not buy aggressively here; I would hold and wait for either a stronger catalyst or a clearer fundamental update.

Technical Analysis

The price is trading near 64.02, slightly above the prior close, with the broader market flat-to-weak. Trend structure is bullish: SMA_5 > SMA_20 > SMA_200, which supports an established uptrend. MACD histogram is positive and expanding, reinforcing short-term momentum. RSI_6 at 68.763 is elevated and close to overbought, which suggests the stock may be extended rather than offering a fresh low-risk entry. Support is around 63.30/62.70, while resistance is near 63.90-64.27; price is already pressing into resistance, so upside from here looks less attractive for a new long-term entry. Overall, trend is bullish but near stretched levels.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is bullish. The open interest put-call ratio of 0.6 suggests more call positioning than puts, and the extremely low option volume put-call ratio of 0.02 indicates heavy call-side activity relative to puts. Implied volatility at 24.68 with IV rank 10.9 implies options are not especially expensive versus recent history, but the current option activity appears strongly directional and bullish. This supports positive sentiment, though it does not by itself make the stock an automatic long-term buy.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
10

Positive Catalysts

  • shows a healthy trend.", "MACD histogram is positive and expanding, indicating improving momentum.", "Options positioning is bullish, with put-call ratios favoring calls.", "Historical pattern estimate suggests positive longer-horizon drift over the next month.", "No recent negative news in the last week."]

Neutral/Negative Catalysts

  • ["No news catalysts in the past week, so there is no fresh event-driven upside driver.", "RSI is near overbought, so the stock may be extended after the recent move.", "No recent significant insider buying, and insiders are neutral.", "Hedge funds are neutral with no meaningful accumulation trend.", "No recent congress trading data or influential figure activity to support conviction.", "No valuation or financial snapshot available to confirm fundamental upside."]

Financial Performance

Latest quarter financials were not available because the financial snapshot returned an error, so there is no usable recent-quarter revenue or earnings growth detail to confirm current business momentum. Because the latest quarter season cannot be verified from the provided data, the fundamental case remains incomplete.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend was provided, so there is no evidence here of recent Wall Street upgrade momentum or target increases. From the available data, Wall Street appears neutral rather than strongly bullish. Pros: trend strength, positive options sentiment, and no recent negative news. Cons: no analyst catalyst, no financial update, neutral hedge fund/insider behavior, and no strong proprietary buy signal.

Wall Street analysts forecast BHF stock price to rise
6 Analyst Rating
Wall Street analysts forecast BHF stock price to rise
0 Buy
5 Hold
1 Sell
Hold
Current: 64.880
sliders
Low
63
Averages
67.6
High
70
Current: 64.880
sliders
Low
63
Averages
67.6
High
70
Keefe Bruyette
Market Perform
initiated
$67
AI Analysis
2026-03-26
Reason
Keefe Bruyette
Price Target
$67
AI Analysis
2026-03-26
initiated
Market Perform
Reason
Keefe Bruyette re-initiated coverage of Brighthouse Financial with a Market Perform rating and $67 price target. The life insurance sector presents a mixed fundamental picture, and while companies have reduced liability tail risk, improved free cash flow conversion, and benefited from stronger growth, they face intensifying competition, rising investment leverage, greater balance sheet complexity, and eventual fading macro tailwinds, the analyst tells investors in a research note.
Barclays
Alex Scott
Overweight -> Equal Weight
downgrade
$65
2026-01-08
Reason
Barclays
Alex Scott
Price Target
$65
2026-01-08
downgrade
Overweight -> Equal Weight
Reason
Barclays analyst Alex Scott downgraded Brighthouse Financial to Equal Weight from Overweight with a $65 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BHF
Unlock Now

People Also Watch